Piracetam (Nootropil®)

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Memory Disorders Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI) Phase 3 N01001
Completed 		NCT00567060 PDF